The deal is expected to close in late Q2 2025, subject to Nevro shareholder and regulatory approval.Globus Medical also reaffirmed its guidance for 2025 net sales of $2.66B to $2.69B and non-GAAP ...

Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...

Prior to the announcement, Globus Medical reported preliminary 2024 sales of $2.52 billion, a 60.6% increase from the previous year, building on its impressive 102.1% revenue growth over the last ...

(RTTNews) - Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, in an all-cash transaction.

Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an all-cash transaction. Under the terms of the agreement ...

Globus Medical (GMED, Financials) agreed to acquire Nevro Corp. (NVRO, Financials) in an all-cash transaction valued at approximately $250 million.Warning! GuruFocus has detected 7 Warning Signs ...

Globus Medical shares have reset after a soft Q1 and Nevro acquisition, making valuations more attractive despite near-term ...

The CEO of Globus Medical said the deal will enable the Audubon company to expand into new markets for future growth. ... Nevro has about 1,100 employees, while Globus has more than 5,000 workers.

Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...